| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Radosław Kaźmierski, Cezary Watała, Edyta Podsiadły, Jolanta Dorszewska, Zofia Adamczewska-Goncerzewicz, Stanisława Tylewska-Wierzbanowska, Wojciech Kozubsk. Carotid intima-media thickness better differentiates between groups of stroke patients and persons without cerebrovascular disease than other conventional and novel risk factors. Folia morphologica. vol 63. issue 3. 2004-12-16. PMID:15478098. |
after adjustment for age, gender and education level, the strongest associations were found between stroke and carotid imt [odds ratio (or) = 10.6; 95% confidence interval (ci): 4.3-26.9] and plaque area (or = 5.4; 95%ci: 2.3-13.1). |
2004-12-16 |
2023-08-12 |
Not clear |
| Radosław Kaźmierski, Cezary Watała, Edyta Podsiadły, Jolanta Dorszewska, Zofia Adamczewska-Goncerzewicz, Stanisława Tylewska-Wierzbanowska, Wojciech Kozubsk. Carotid intima-media thickness better differentiates between groups of stroke patients and persons without cerebrovascular disease than other conventional and novel risk factors. Folia morphologica. vol 63. issue 3. 2004-12-16. PMID:15478098. |
of the clinical risk factors, a significant association was found between stroke and coronary heart disease (or = 3.5; 95%ci: 1.2-10.2), hypertension (or = 3.2; 95%ci: 1.5-7.2) and smoking (or = 2.7; 95%ci: 1.1-6.4). |
2004-12-16 |
2023-08-12 |
Not clear |
| Radosław Kaźmierski, Cezary Watała, Edyta Podsiadły, Jolanta Dorszewska, Zofia Adamczewska-Goncerzewicz, Stanisława Tylewska-Wierzbanowska, Wojciech Kozubsk. Carotid intima-media thickness better differentiates between groups of stroke patients and persons without cerebrovascular disease than other conventional and novel risk factors. Folia morphologica. vol 63. issue 3. 2004-12-16. PMID:15478098. |
from the laboratory-derived risk factors a significant association was found between stroke and triglyceride levels (or = 4.4; 95%ci: 1.9-10.0), and an inverse correlation was observed between stroke occurrence and hdl-cholesterol level (or = 0.4; 95%ci: 0.2-0.8). |
2004-12-16 |
2023-08-12 |
Not clear |
| Sujoya Dey, Debabrata Mukherje. Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases. Current vascular pharmacology. vol 1. issue 3. 2004-12-01. PMID:15320479. |
in our institutional peripheral interventional database, after adjustment for demographics and comorbidities, statin therapy (or=0.21, 95% ci 0.05-0.86, p=0.03) and clopidogrel therapy (or=0.17, 95% ci 0.04-0.78, p=0.02) were both associated with a significant reduction of the composite event rate of death, myocardial infarction and stroke at 6 months. |
2004-12-01 |
2023-08-12 |
Not clear |
| B Dahlöf, T A Burke, K Krobot, G W Carides, J M Edelman, R B Devereux, H-C Diene. Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Journal of human hypertension. vol 18. issue 6. 2004-10-19. PMID:15029217. |
in life, the losartan-based treatment further reduced the primary composite end point (cardiovascular death, myocardial infarction, or stroke) by 13% (risk reduction (rr) 0.87, 95% confidence interval (ci) 0.77-0.98, p=0.021). |
2004-10-19 |
2023-08-12 |
Not clear |
| B Dahlöf, T A Burke, K Krobot, G W Carides, J M Edelman, R B Devereux, H-C Diene. Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Journal of human hypertension. vol 18. issue 6. 2004-10-19. PMID:15029217. |
the further reduction in stroke with losartan (rr 0.75, 95% ci 0.63-0.89, p=0.001) was the major contributing factor to the reduction in the primary end point. |
2004-10-19 |
2023-08-12 |
Not clear |
| H M Reims, S E Kjeldsen, W E Brady, B Dahlöf, R B Devereux, S Julius, G Beevers, U De Faire, F Fyhrquist, H Ibsen, K Kristianson, O Lederballe-Pedersen, L H Lindholm, M S Nieminen, P Omvik, S Oparil, H Wede. Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study. Journal of human hypertension. vol 18. issue 6. 2004-10-19. PMID:15103313. |
composite risk was significantly reduced with losartan compared to atenolol only in abstainers (hr 0.81 95% confidence interval, ci (0.68, 0.96), p<0.05), while benefits for stroke risk reduction were similar among participants consuming 1-7 drinks/week (hr 0.73, p<0.05) and abstainers (hr 0.72, p<0.01). |
2004-10-19 |
2023-08-12 |
human |
| Peter M Okin, Richard B Devereux, Markku S Nieminen, Sverker Jern, Lasse Oikarinen, Matti Viitasalo, Lauri Toivonen, Sverre E Kjeldsen, Stevo Julius, Steven Snapinn, Björn Dahlö. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension (Dallas, Tex. : 1979). vol 44. issue 1. 2004-09-28. PMID:15173125. |
in cox analyses adjusting only for treatment effect, ecg strain was a significant predictor of cv death (hazard ratio [hr] 2.26, 95% confidence interval [ci] 1.78 to 2.86), fatal/nonfatal myocardial infarction (hr 2.16, 95% ci 1.67 to 2.80), fatal/nonfatal stroke (hr 1.76, 95% ci 1.39 to 2.21), and the composite cv end point (hr 1.99, 95% ci 1.70 to 2.33). |
2004-09-28 |
2023-08-12 |
Not clear |
| Jerry L Spivak, Giovanni Barosi, Gianni Tognoni, Tiziano Barbui, Guido Finazzi, Roberto Marchioli, Monia Marchett. Chronic myeloproliferative disorders. Hematology. American Society of Hematology. Education Program. 2004-09-23. PMID:14633783. |
aspirin treatment lowered the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke (relative risk 0.41 [95% ci 0.15-1.15], p =.0912). |
2004-09-23 |
2023-08-12 |
human |
| R Deschamps, S Olindo, P Cabre, S Elysée, P Fournerie, D Smadj. [A prospective epidemiological and aetiological study of strokes in young Afro-Caribbean patients from Martinique, French West Indies]. Revue neurologique. vol 160. issue 3. 2004-09-20. PMID:15037844. |
hypertension was the most prevalent stroke risk factor: 35p.cent in ci and 68p.cent in ich. |
2004-09-20 |
2023-08-12 |
Not clear |
| Carl van Walraven, Robert G Hart, Daniel E Singer, Peter J Koudstaal, Stuart Connoll. Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in. Cardiac electrophysiology review. vol 7. issue 4. 2004-08-26. PMID:15071258. |
patients receiving oac had a significantly lower risk of any stroke (hazard ratio [hr] 0.54 [95% ci 0.43-0.71]), ischemic stroke (hr 0.48 [0.37-0.63]), or cardiovascular events (hr 0.71 [0.59-0.85]). |
2004-08-26 |
2023-08-12 |
Not clear |
| Jiann-Shing Jeng, Sung-Chun Tang, Ping-Keung Yi. Stroke in women of reproductive age: comparison between stroke related and unrelated to pregnancy. Journal of the neurological sciences. vol 221. issue 1-2. 2004-08-19. PMID:15178209. |
stroke was categorized as cerebral infarction (ci), cerebral hemorrhage (ch), or subarachnoid hemorrhage (sah) and divided into subtype according to etiology. |
2004-08-19 |
2023-08-12 |
Not clear |
| Bernhard Strohmer, Max Pichler, Martin Froemmel, Mario Migschitz, Florian Hintringe. Evaluation of atrial conduction time at various sites of right atrial pacing and influence on atrioventricular delay optimization by surface electrocardiography. Pacing and clinical electrophysiology : PACE. vol 27. issue 4. 2004-07-30. PMID:15078399. |
optimization of av delay resulted in a relative increase of echocardiographic stroke volume (sv) (10.9 +/- 13.7%; 95% ci: 5.9-15.9%) when compared to nominal av delay (170 ms). |
2004-07-30 |
2023-08-12 |
Not clear |
| C D Bushnell, L K Newby, L B Goldstein, F Lin, K Yaffe, J A Simo. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. vol 62. issue 6. 2004-07-19. PMID:15037702. |
despite large reductions in relative risk point estimates, statin use was not associated with differences in the risks of all fatal stroke (relative hazard [rh] 0.52, 95% ci 0.23 to 1.18, p = 0.12), fatal ischemic stroke (rh 0.51, 95% ci 0.18 to 1.45, p = 0.21), fatal hemorrhagic stroke (rh 0.18, 95% ci 0.02 to 1.46, p = 0.11), or tia (rh 1.32, 95% ci 0.84 to 2.09, p = 0.23). |
2004-07-19 |
2023-08-12 |
Not clear |
| Remigiusz Zieba, Małgorzata Wagrowska-Danilewic. Influence of carnosine on the cardiotoxicity of doxorubicin in rabbits. Polish journal of pharmacology. vol 55. issue 6. 2004-06-15. PMID:14730104. |
the following hemodynamic parameters were estimated: heart rate (hr), mean arterial pressure (map), cardiac index (ci), stroke index (si) and total peripheral resistance (tpr). |
2004-06-15 |
2023-08-12 |
rabbit |
| E Kumral, G Bayulkem, C Ataç, Y Alpe. Spectrum of superficial posterior cerebral artery territory infarcts. European journal of neurology. vol 11. issue 4. 2004-05-24. PMID:15061825. |
features of the stroke that was associated with significant increased risk of poor outcome included, consciousness disturbances at stroke onset (rr, 66.6; 95% ci, 8.6-515.5), mesencephalic and/or thalamic involvement (rr, 3.79; 95% ci, 1.49-9.65), plad (rr, 2.71; 95% ci, 1.09-6.73), and basilar artery disease (rr, 5.94; 95% ci, 1.73-20.47). |
2004-05-24 |
2023-08-12 |
Not clear |
| Philip A Tea. Recent clinical trial results with antiplatelet therapy: implications in stroke prevention. Cerebrovascular diseases (Basel, Switzerland). vol 17 Suppl 3. 2004-04-29. PMID:14730252. |
clopidogrel in combination with asa reduced the relative risk of the combined atherothrombotic endpoint of cardiovascular death, mi or stroke by 20% (95% ci 0.72-0.90; p < 0.001) and the absolute risk of this composite endpoint by 2.1%. |
2004-04-29 |
2023-08-12 |
Not clear |
| Vesa Karttunen, Leena Hiltunen, Vesa Rasi, Elina Vahtera, Matti Hillbo. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. vol 14. issue 3. 2004-04-20. PMID:12695749. |
prothrombotic states [odds ratio (or) 2.8; 95% confidence interval (ci), 1.2-6.5; p = 0.021], migraine with aura (or 4.4; 95% ci 1.8-10.8; p = 0.001) and classical risk factors for venous thrombosis (or 2.5; 95% ci 1.1-5.7; p = 0.037) were independent risk factors for cryptogenic stroke. |
2004-04-20 |
2023-08-12 |
human |
| Egbert Huettemann, Thomas Junker, Kyriasis P Chatzinikolaou, Gritta Petrat, Samir G Sakka, Lothar Vogt, Konrad Reinhar. The influence of anthracycline therapy on cardiac function during anesthesia. Anesthesia and analgesia. vol 98. issue 4. 2004-04-19. PMID:15041577. |
compared with baseline (sf: 34.9 +/- 3.7 [ac], 34.1 +/- 3.7 [c] [not significant]; stroke volume index [svi] 36 +/- 6 ml/m(2)[ac], 35 +/- 4 ml/m(2)[c] [not significant]; cardiac index [ci] 3.6 +/- 0.6 l/min/m(2)[ac], 3.2 +/- 0.5 l/min/m(2)[c] [not significant]), we found a significant decrease in sf and svi in both groups at t1 (sf: 26.2 +/- 3.6 [ac] versus 28.6 +/- 3.6 [c] [p < 0.05]; svi: 26 +/- 4 ml/m(2) [ac] versus 30 +/- 46 ml/m(2) [c] [p < 0.05]) and t2 (sf: 24.1 +/- 3.2 [ac] versus 28.2 +/- 2.5 [c] [p < 0.01], svi: 26 +/- 6 ml/m(2) [ac] versus 31 +/- 5 ml/m(2) [c] [p < 0.01]), which was significantly greater in the ac group. |
2004-04-19 |
2023-08-12 |
Not clear |
| Carolyn Hoppe, William Klitz, Suzanne Cheng, Ray Apple, Lori Steiner, Lara Robles, Tom Girard, Elliott Vichinsky, Lori Style. Gene interactions and stroke risk in children with sickle cell anemia. Blood. vol 103. issue 6. 2004-04-15. PMID:14615367. |
the combination of tnf (-308)gg homozygosity and the il4r 503p variant carrier status was associated with a particularly strong predisposition to lv stroke (odds ratio [or] = 5.5; 95% confidence interval [ci] = 2.3-13.1). |
2004-04-15 |
2023-08-12 |
Not clear |